CN114577916B - Analysis method of stable isotope labeling metabolic flow based on chip nanoliter electrospray mass spectrum - Google Patents

Analysis method of stable isotope labeling metabolic flow based on chip nanoliter electrospray mass spectrum Download PDF

Info

Publication number
CN114577916B
CN114577916B CN202011387929.6A CN202011387929A CN114577916B CN 114577916 B CN114577916 B CN 114577916B CN 202011387929 A CN202011387929 A CN 202011387929A CN 114577916 B CN114577916 B CN 114577916B
Authority
CN
China
Prior art keywords
stable isotope
labeled
metabolites
mass spectrum
mass
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011387929.6A
Other languages
Chinese (zh)
Other versions
CN114577916A (en
Inventor
许国旺
于迪
周丽娜
郑福建
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalian Institute of Chemical Physics of CAS
Original Assignee
Dalian Institute of Chemical Physics of CAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalian Institute of Chemical Physics of CAS filed Critical Dalian Institute of Chemical Physics of CAS
Priority to CN202011387929.6A priority Critical patent/CN114577916B/en
Publication of CN114577916A publication Critical patent/CN114577916A/en
Application granted granted Critical
Publication of CN114577916B publication Critical patent/CN114577916B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/62Detectors specially adapted therefor
    • G01N30/72Mass spectrometers
    • G01N30/7233Mass spectrometers interfaced to liquid or supercritical fluid chromatograph
    • G01N30/724Nebulising, aerosol formation or ionisation
    • G01N30/7266Nebulising, aerosol formation or ionisation by electric field, e.g. electrospray
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8675Evaluation, i.e. decoding of the signal into analytical information

Abstract

The invention discloses an analysis method of stable isotope labeling metabolic flow based on a chip nanoliter electrospray mass spectrum. The metabolites in the cells are directly extracted by adopting methanol/water, transferred to a sample injection disc, added with a spraying solvent, and directly injected into a mass spectrometer for analysis through a chip-based multichannel nano-liter electrospray ion source. And obtaining the metabolite information marked by the stable isotope by adopting a full scanning and parallel reaction monitoring mode and combining a self-programmed secondary mass spectrum matching operation program. And quantifying the stable isotope labeled metabolites in the sample by adopting a parallel reaction monitoring mode. The analysis method can carry out quantitative analysis on the stable isotope labeled metabolites in a small amount of cells, and the analysis time is greatly shortened by direct sample injection. The method has the advantages of simple pretreatment, economy, high efficiency, high sensitivity and high flux.

Description

Analysis method of stable isotope labeling metabolic flow based on chip nanoliter electrospray mass spectrum
Technical Field
The invention relates to the fields of analytical chemistry and stable isotope labeling and tracing, in particular to an analysis method for quantitatively stabilizing isotope labeling metabolic flow by adopting a parallel reaction monitoring mode based on a chip nanoliter electrospray mass spectrum, a labeled metabolite is obtained according to matching of a primary mass spectrum and a secondary mass spectrum.
Background
Metabolic reprogramming is an important feature of a variety of diseases. Traditional metabonomics analysis can only reflect static metabolite concentration information, and lacks dynamic process information of biochemical reaction. Based on a stable isotope tracing method and assisted dynamic process information analysis, the change of metabolites in organisms and the functional verification of metabolic pathways can be known, and the method can be used for exploring the occurrence mechanism and treatment scheme of diseases.
The existing quantitative method for the stable isotope labeling metabolic flux comprises gas chromatography-mass spectrometry, liquid chromatography-mass spectrometry and capillary electrophoresis-mass spectrometry. These methods require millions of cells and are not suitable for rare samples. One culture requires about 10mL of a substrate labeled with a stable isotope, and the substrate labeled with a stable isotope is expensive and uneconomical. In addition, the analysis time is long. In conclusion, it is necessary to develop a high-throughput stable isotope-labeled metabolic flux assay for small samples.
The research adopts a chip-based multichannel nanoliter electrospray ion source to directly inject a sample into a mass spectrometer for analysis, and only about 10000 cells and 100 mu L of culture medium are needed for analysis at least once. The method can be used for analyzing rare samples, reduces the cost of culture medium, and is more economical. In addition, the pretreatment method is simple and convenient, the analysis time is short, and the method is favorable for the analysis of large-scale samples. There have been no reports to date of the application of the method of the present invention to stable isotope-labeled metabolic flux analysis.
Disclosure of Invention
In order to realize stable isotope labeled metabolic flow, the invention establishes an analysis method based on chip nanoliter electrospray mass spectrometry and adopting a parallel reaction monitoring mode to quantify the stable isotope labeled metabolic flow. The method has the advantages of simple pretreatment, economy and colleges, small required sample size, short analysis time, comprehensive information acquisition and the like.
The specific technical method adopted by the invention is as follows:
(1) The cells are cultured in two media, one stable isotope-labeled medium containing stable isotope-labeled metabolites, e.g. 13 C 6 -a glucose, 13 c-1,2-glucose, 13 C 3 -pyruvic acid, 13 C 5 -a source of glutamine, 15 N 2 -a source of glutamine, 13 C 5 - 15 N 2 -a source of glutamine, 2 H 3 -serine, etc.; the other is an unstable isotope labeled medium which contains metabolites that are not labeled with stable isotopes and at a concentration consistent with the stable isotope labeled metabolites in the stable isotope labeled medium. Cells are cultured in 6-well, 12-well, 24-well, 96-well or 10cm culture plates, and the cell density of one well reaches 50% -90%. The medium was discarded and washed twice with PBS. Counting the cells, adding 50-100 μ L of 80% methanol/water extracting agent containing 5-20 μ M methionine sulfone and camphorsulfonic acid sodium salt as internal standard per 10000-20000 cells. Covering with aluminum foil paper and sealing film, and standing at 3-5 deg.C for 30-40min.
(2) Transfer 20-40 μ L of extract to 96-well template and add equal volume of spray solvent. In the positive ion detection mode, the spray solvent is 60-80% methanol/water (v/v) containing 0.3-0.5% formic acid; in the negative ion detection mode, the spray solvent is 60-80% methanol/water (v/v) containing 10-30mM ammonium acetate and 0.03-0.05% formic acid. The ions are directly injected into the mass spectrometer through a chip-based multichannel nanoliter electrospray ion source.
(3) And performing mass spectrometry on the cell extracting solution cultured in the stable isotope labeling culture medium and the cell extracting solution cultured in the non-stable isotope labeling culture medium by adopting a full-scanning monitoring mode to obtain first-level intensity information. And filtering metabolites with the signal-to-noise ratio of less than 3, which appear in less than 60-80% of repeated samples for multiple times and exist in blank by primary mass spectrum filtration to obtain a characteristic ion table stably existing in the unlabeled and labeled cell extracting solution. Wherein the blank sample refers to a blank solvent without containing the cell sample, namely a mixed solution of an extracting agent and a spraying solvent. According to the precise mass number (abbreviated as M) of the characteristic ions stably existing in the unmarked part, the precise mass number (abbreviated as M + n, n refers to the number of atoms marked by the stable isotope) of the corresponding isotope on the mark is calculated and matched with the characteristic ions stably existing in the marked cell extracting solution. If there is a match, the metabolite is considered to be a potential labeled metabolite. If not, neglect.
(4) And (3) carrying out parallel reaction monitoring mode mass spectrometry on the cell extracting solution cultured in the stable isotope labeling culture medium and the cell extracting solution cultured in the non-stable isotope labeling culture medium aiming at the potential labeled metabolites to obtain secondary mass spectrum information of the cell extracting solution. In a stable isotope labeled sample, secondary mass spectrograms of accurate mass numbers M and M + n are respectively extracted, all secondary ions (abbreviated as M → Mp) are generated according to M, the mass number of the secondary ions labeled by the stable isotope is calculated, and the secondary mass spectrograms are matched with the secondary mass spectrograms of M + n (abbreviated as M + n → Mp + M, M refers to the number of atoms labeled by the stable isotope, and M is less than or equal to n). The matching rules are equal at a mass deviation of 5-20 ppm. If not, it is ignored. And if the intensities are matched, calculating the ratio of the Mp + m intensity to the Mp intensity. Meanwhile, M → Mp and M + n → Mp + M are extracted from the sample without stable isotope labeling, the ratio of the intensity of Mp + M to the intensity of Mp is calculated, and if the value obtained by multiplying the ratio of the intensity of Mp + M to the intensity of Mp in the sample without stable isotope labeling by 1.0-1.2 is smaller than the ratio of the intensity of Mp + M to the intensity of Mp in the sample with stable isotope labeling, M and M + n are considered as a pair of non-labeled and labeled metabolites, and respectively contain secondary fragments Mp and Mp + M. According to the above rules, stable isotope labeled metabolites were found, and their primary and secondary mass spectral information was used for qualitative and quantitative analysis.
(5) And obtaining the ion pairs of the labeled metabolites through the primary and secondary mass spectrum information of the labeled metabolites, and carrying out quantitative analysis by adopting a parallel reaction monitoring mode. The conditions for the parallel reaction monitoring mode were: the maximum ion collection time is 100-200 ms, each 0.1-0.3 s is a time period, and no more than 50 ions are contained in one time period, so that at least 5 points are collected for each ion. And simultaneously, collecting the intensity of the internal standard in a whole section. For each ion, the intensity was divided by the internal standard intensity at the same time, and the average of 5 points was taken as a semi-quantitative result.
The method only needs 10000 cells and 10 mu L of culture medium at least, is more economical and can be used for analyzing rare samples; the extraction solution is directly injected into the mass spectrum by adopting a chip nanoliter electrospray ion source, and compared with the traditional method for combining the chromatographic mass spectrum, the sensitivity is improved, and the analysis time is shortened; and acquiring primary and secondary mass spectrum information by adopting a full-scanning and parallel reaction monitoring mode, and after accurate mass number and intensity screening is carried out, finding out the labeled metabolite to acquire comprehensive primary and secondary mass spectrum information for labeling the metabolite.
Drawings
FIG. 1 illustrates a two-stage mass matching process, exemplified by 116.0705 and 121.0872.
FIG. 2 metabolic changes of isocitrate dehydrogenase mutant U251 human glioma cells under the action of triptolide.
Table 1 positive ion mode, potential labeled ions.
Table 2 negative ion mode, potential labeled ions.
Table 3 labeled ions and their secondary mass spectral information in positive ion mode.
Table 4 information of labeled ions and their secondary mass spectra in negative ion mode.
Detailed Description
Embodiments of the invention are described in detail below with reference to the attached table drawings: the embodiments are implemented on the premise of the technical scheme of the invention, and detailed implementation modes and specific operation processes are given, but the protection scope of the invention is not limited by the following embodiments.
Example one
Based on chip nanoliter electrospray mass spectrometry, full-scan and parallel reaction monitoring mode analysis, the carbon source metabolic flow of glutamine is analyzed.
(1) Cell culture and pretreatment: u251 cells were cultured in 96-well culture plates to a density of 90%, i.e., about 10000 cells per well. The culture medium is Du's medium (DMEM) containing 4mM glutamine, and the culture medium contains stable isotope labeled glutamine (4 mM) 13 C 5 -glutamine) DMEM. After 1 day of incubation, the medium was discarded and washed twice with PBS. 50 μ L of 80% methanol/water extract containing 10 μ M methionine sulfone and camphorsulfonic acid sodium salt as internal standard was added. Covering with aluminum foil paper and sealing film, and standing at 4 deg.C for 30min. Each sample was replicated 4 times.
(2) Transfer 20. Mu.L of each extract to 2 96-well plates, add 20. Mu.L of 80% methanol/water (v/v) containing 0.5% formic acid (v/v) to one plate for positive ion mode detection; another plate was loaded with 20. Mu.L of 80% methanol/water (v/v) containing 20mM ammonium acetate and 0.04% formic acid (v/v) for negative ion mode detection. The ions are directly injected into the mass spectrometer through a chip-based multichannel nanoliter electrospray ion source.
(3) Full scan mode mass spectrometry conditions: ESI source, positive ion mode and negative ion mode.
(4) And filtering according to the first-class mass spectrum information, and filtering metabolites which are present in a blank and have the signal-to-noise ratio of less than 3 and appear in the quadruplicate samples for less than three times to obtain a characteristic ion table stably existing in the unlabeled and labeled cell extracting solution. According to the precise mass number (abbreviated as M) of the characteristic ions stably existing in the unmarked part, the precise mass number (abbreviated as M + n, n refers to the number of atoms marked by the stable isotope) of the corresponding isotope on the mark is calculated and matched with the characteristic ions stably existing in the marked cell extracting solution. If they match, they are considered as potential labeled metabolites, and the potential mass numbers are shown in attached tables 1 and 2. If not, neglecting
(5) Parallel reaction monitoring mode mass spectrometry conditions: ESI source, positive ion mode and negative ion mode, collision energy is 15eV,30eV,45eV. And (4) aiming at the potential labeled metabolites in the step (4), carrying out parallel reaction monitoring mode analysis on the cell extract cultured in the stable isotope labeled culture medium and the cell extract cultured in the non-stable isotope labeled culture medium to obtain the second-order mass spectrum information of all ions.
(6) From the secondary mass spectral information, the labeled metabolites were confirmed: in a stable isotope labeled sample, extracting secondary mass spectrograms of accurate mass numbers M and M + n respectively, generating all secondary ions (abbreviated as M → Mp) according to M, calculating the mass numbers of the secondary ions labeled by the stable isotope, namely M, M +1 x 1.003355, M +2 x 1.003355, M +3 x 1.003355, M +4 x 1.003355, M +5 x 1.003355, and matching with the secondary mass spectrograms of M + n (abbreviated as M + n → Mp + M, n and M refer to the number of atoms labeled by the stable isotope, wherein M is not more than n). The matching rule is at 10Mass deviation in ppm is equal. If not, neglect. And if the intensities are matched, calculating the ratio of the Mp + m intensity to the Mp intensity. Meanwhile, M → Mp and M + n → Mp + M are extracted from the sample not containing stable isotope labeling, the ratio of the intensity of Mp + M to the intensity of Mp is calculated, and if it is smaller than the ratio of the intensity of Mp + M to the intensity of Mp in the sample labeled with stable isotope, M and M + n are considered as a pair of unlabeled and labeled metabolites, containing secondary fragments Mp and Mp + M, respectively. Taking the potentially labeled ions with M and M + n of 116.0705 and 121.0872 as an example, the specific process is shown in FIG. 1. Firstly, firstly 13 C 5 Glutamine-labeled samples, accurate mass number plus 0,1 x 1.03355,2 x 1.03355,3 x 1.03355,4 x 1.03355,5 x 1.03355 for each secondary fragment of 116.0705, and secondary fragments of 121.0872 were searched for the presence of ions with accurate mass within 5 ppm. Four pairs of ions were found with an exact mass number difference of N1.003355 with N =0,1,2,3,4,5. The intensity ratio of the secondary fragments is calculated and is recorded as ratio _13. Second, in the unlabeled samples, the secondary patch intensities of the corresponding 116.0705 and 121.0872 are extracted, and the ratio _12 is calculated. A secondary fragment is considered to be its secondary fragment when its ratio _13 is greater than 1.1 times ratio _12 and the absolute intensity of the secondary fragment in the marked sample is greater than it is in the unmarked sample. In FIG. 1, the limit of ratio _12, where ratio _13 is greater than 1.1 times, excludes 74.0598 and 75.0632; the absolute intensity of the secondary fragment in the labeled sample was greater than its limit in the unlabeled sample, excluding 56.0495 and 57.0530. For the potential labeled metabolites of 1160705 and 121.0872, the corresponding 70.0650 and 74.0784 fragments were found. According to the above rules, stable isotope labeled metabolites were found, and their primary and secondary mass spectral information was used for qualitative and quantitative purposes.
(7) Characterization of the labeled metabolites: the labeled metabolites were characterized according to the HMDB database, in combination with the existing secondary information. Taking 1116.0705 in step (6) as an example, it contains 70.0650 characteristic fragment, and it is presumed to be proline from the database.
Finally, in positive ion mode 55 labelled metabolites were detected, 13 of which were characterised. In negative ion mode, 35 labeled metabolites were detected, 16 of which were characterized. The information and qualitative information of the primary and secondary mass spectra of the labeled metabolites is shown in attached table 3 and attached table 4.
Example two
Isocitrate dehydrogenase I mutated human glioma cells (U251 IDH 1) RH ) Glutamine metabolism pathway change under action of triptolide
(1) Cell culture and pretreatment: u251 cells were cultured in 96-well culture plates to a density of 70%, i.e., approximately 10000 cells per well. The culture medium contains stable isotope labeled glutamine (4 mM) 13 C 5 -glutamine) DMEM. Adding 0nM and 120nM triptolide, and culturing for 12h. The medium was discarded and washed twice with PBS. 50 μ L of 80% methanol/water extractant containing 5-20 μ M methionine sulfone and camphorsulfonic acid sodium salt as internal standard was added. Covering with aluminum foil paper and sealing film, and standing at 4 deg.C for 30min.
(2) Transferring 20 μ L of the extract to 2 96-well sample plates, one of which is added 20 μ L of 80% methanol/water containing 0.5% formic acid for positive ion mode detection; the other plate was charged with 20. Mu.L of 80% methanol/water containing 20mM ammonium acetate and 0.04% formic acid for negative ion mode detection. The ions are directly injected into the mass spectrometer through a chip-based multichannel nanoliter electrospray ion source.
(3) And carrying out parallel reaction monitoring mode analysis on the labeled metabolites to obtain secondary information for quantification. Mass spectrum conditions: ESI source, positive ion mode and negative ion mode, collision energy of 15ev,30ev,45ev, maximum ion collection time of 200ms, a time period of about 12 ions per 0.2s, contained in one time period to ensure that at least 5 points were collected per ion.
(4) For each ion, the intensity was divided by the internal standard intensity at the same time, and the average of 5 points was taken as a semi-quantitative result. Using the Mann-Whitney rank sum test, triptolide treated and untreated U251 IDH1 were found RH Metabolites with significant differences among cells are shown in fig. 2, and in fig. 2, blue is a metabolite from which glutamine is significantly reduced after treatment with triptolide. Black is noThere are significant differences. The triptolide can influence U251 IDH1 by inhibiting glutathione synthesis and tricarboxylic acid cycle RH Metabolism of the cell.
TABLE 1 potential labeled ions in Positive ion mode
No. M M+1 M+2 M+3 M+4 M+5 No. M M+1 M+2 M+3 M+4 M+5
1 103.0388 107.0522 108.0555 63 248.9987 254.0154
2 103.9735 108.99 64 249.9826 252.9927 254.9994
3 105.0545 110.0712 65 250.9667 255.9833
4 107.0701 108.0735 112.0868 66 250.9951 256.0127
5 114.0661 116.0729 119.083 67 251.9797 256.9964
6 114.0733 119.0895 68 259.0276 264.0442
7 116.0525 120.0654 121.0688 69 264.9728 269.9893
8 116.0705 117.0738 118.0772 119.0806 120.0839 121.0873 70 265.9567 270.9733
9 119.0806 120.0839 121.0873 124.0968 71 267.9538 272.9702
10 124.9999 130.0168 72 271.9646 274.9745 276.9817
11 130.0498 131.0532 133.0601 134.0632 135.0666 73 272.9487 277.9654
12 131.0563 136.0733 74 273.9618 278.9785
13 132.0768 133.0801 137.0936 75 274.9456 279.9625
14 133.097 138.1139 76 275.0015 280.018
15 139.0155 144.0323 77 281.9935 287.0112
16 145.0471 149.0602 150.0645 78 282.9776 287.9937
17 147.0764 148.0796 151.0897 152.0931 79 285.9672 290.9849
18 148.0604 149.0637 150.0671 151.0703 152.0737 153.0771 80 287.9385 292.9552
19 149.0573 154.0741 81 288.9223 293.9391
20 149.0808 154.0973 82 289.017 294.0335
21 150.0646 155.0815 83 289.9357 294.9526
22 151.0479 154.0585 156.0644 84 290.0009 295.018
23 152.0318 153.035 155.0422 157.0485 85 290.985 296.0017
24 153.0158 157.0299 158.0333 86 305.9751 310.9915
25 156.0767 161.0935 87 306.9579 311.974
26 161.0692 166.0862 88 307.0829 312.0999
27 162.076 167.0929 89 308.0907 311.1007 312.104 313.1074
28 166.071 171.0877 90 309.0945 312.104 313.1074 314.1108
29 169.0583 170.0616 173.0717 174.075 91 310.0863 315.1031
30 170.0423 171.0456 172.049 173.0524 174.0558 175.0591 92 310.0956 315.1123
31 170.0924 175.1091 93 310.9989 316.0155
32 171.0263 172.0296 173.0331 174.0364 175.0398 176.0431 94 311.9828 316.9995
33 171.0304 176.0472 95 312.9668 317.9838
34 173.0305 178.0474 96 327.9567 332.9732
35 173.0421 178.0586 97 329.9232 334.9397
36 173.1171 178.1338 98 330.0726 331.076 332.079 333.0826 334.0858 335.0892
37 175.1189 176.1222 180.1357 99 330.9069 335.9238
38 176.0658 181.0833 100 331.0763 334.0858 335.0892 336.0929
39 176.103 181.1196 101 332.0682 335.0782 337.0849
40 185.0211 190.0374 102 333.9648 338.9822
41 185.0322 190.0489 103 334.9486 339.965
42 186.0162 189.0262 191.0329 104 336.0856 337.0888 339.0958 341.102
43 186.9677 191.9854 105 338.1014 343.118
44 187.0002 188.0035 190.0102 192.0169 106 339.0772 344.0933
45 187.0304 189.0372 192.047 107 345.9705 350.9868
46 189.0158 194.0318 108 346.0469 349.0567 351.0634
47 191.0401 196.0569 109 349.9386 354.9553
48 192.0241 193.0274 195.0342 196.0375 197.0409 110 352.0544 355.0646 356.0675 357.0711
49 193.0083 196.0182 198.0249 111 354.0962 357.106 358.1096 359.1127
50 196.0571 201.0732 112 355.0996 357.106 358.1096 359.1127 360.116
51 200.0404 205.0567 113 356.0915 361.1082
52 205.0335 210.05 114 358.0669 363.0843
53 207.0141 212.0308 115 360.0467 365.0636
54 207.9981 211.0082 213.0148 116 368.0288 373.0452
55 208.9821 211.9921 213.9988 117 368.1117 371.1217 372.1254 373.1285
56 212.0891 217.1066 118 369.1148 371.1217 372.1254 373.1285 374.1319
57 215.0512 220.0675 119 374.0363 377.0464 379.0531
58 216.0144 221.0303 120 376.0779 377.0814 379.088 381.0945
59 217.0192 219.0263 220.0298 222.035 121 390.0103 395.0272
60 224.1257 229.1415 122 391.9229 396.9404
61 229.9801 234.9967 123 398.0599 403.0766
62 230.9641 235.9808 124 402.1191 407.1353
TABLE 1. Potential labeled ions in positive ion mode
No. M M+1 M+2 M+3 M+4 M+5 No. M M+1 M+2 M+3 M+4 M+5
125 420.04 425.06 189 275.99 280
126 432 437.01 190 297.97 301.98
127 450.03 455.05 191 311.09 315.1
128 70.065 74.078 192 322.11 326.12
129 74.024 78.037 193 353.06 355.06 356.07 357.07
130 84.044 86.051 88.058 194 375.04 377.05 379.05
131 89.107 93.121 195 377.08 379.09 381.09
132 95.031 99.044 196 88.039 91.049
133 101.06 102.06 105.07 197 90.055 91.058 93.065
134 101.07 105.08 198 102.06 105.07
135 102.05 103.06 104.06 106.07 199 103.06 104.06 106.07
136 108.07 112.09 200 107.05 110.06
137 110.06 114.07 201 120 123.01
138 111.01 115.02 202 121.09 124.1
139 112.98 117 203 131.07 134.08
140 116.03 120.05 204 135.05 136.05 137.05 138.06
141 117.07 118.08 119.08 120.08 121.09 205 137.03 139.04 140.04
142 121.04 123.04 125.05 206 138.05 141.06
143 131.05 133.06 134.06 135.07 207 147.17 148.17 150.18
144 133.06 137.07 208 150.07 153.08
145 133.08 137.09 209 157.03 158.03 159.04 160.04
146 134.04 135.05 136.05 137.05 138.06 210 173.09 176.1
147 137.06 138.06 141.07 211 184.06 185.06 186.06 187.07
148 139.04 140.04 143.05 212 184.56 185.56 186.57 187.57
149 141.02 145.03 213 185.06 188.07
150 146.17 147.17 148.17 150.18 214 189.04 192.05
151 148.08 151.09 152.09 215 204.23 205.23 207.24
152 149.06 150.07 151.07 152.07 153.08 216 214.01 217.02
153 156.03 157.03 158.03 159.04 160.04 217 214.99 218
154 156.95 160.97 218 311.1 312.1 313.11 314.11
155 157.01 159.02 161.02 219 81.031 83.037
156 157.01 161.03 220 83.022 85.028
157 159.1 163.12 221 91.058 93.065
158 160.92 164.93 222 105 107.01
159 170.06 173.07 174.08 223 110.01 112.02
160 171.04 175.06 224 111.02 113.02
161 171.05 172.05 173.05 174.06 175.06 225 111.05 113.06
162 172 176.01 226 119.02 120.02 121.03
163 172.03 173.03 174.04 175.04 176.04 227 123.01 125.02
164 178.01 179.01 180.02 182.02 228 123.04 125.05
165 178.99 183.01 229 133.03 135.04
166 186.04 190.05 230 136.05 137.05 138.06
167 187.02 189.03 191.03 231 139.06 141.06
168 187.04 191.05 232 142.03 144.04
169 188 190.01 192.02 233 147.05 149.06
170 192.04 196.06 234 151.05 153.05
171 193.03 195.03 196.04 197.04 235 151.07 152.07 153.08
172 193.98 198 236 167.06 169.06
173 194.01 196.02 198.02 237 174.04 175.04 176.04
174 198.04 202.05 238 185.06 186.06 187.07
175 199.99 204 239 215.02 217.02
176 201.11 205.13 240 239.15 241.16
177 203.22 204.23 205.23 207.24 241 307.58 309.59
178 211.08 215.09 242 338.34 340.35
179 223.11 227.13 243 369.35 370.35 371.36
180 226.95 227.95 230.96 244 64.016 65.019
181 230.99 235 245 73.065 74.068
182 235.97 239.98 246 74.06 75.063
183 237 241.01 247 76.039 77.043
184 237.97 241.99 248 84.081 85.084
185 246 250.01 249 86.096 87.1
186 251.94 255.95 250 87.044 88.047
187 257.95 261.96 251 89.06 90.063
188 273.92 277.94 252 90.977 91.98
TABLE 1. Potential labeled ions in positive ion mode
No. M M+1 M+2 M+3 M+4 M+5 No. M M+1 M+2 M+3 M+4 M+5
253 94.065 95.068 317 197.08 198.08
254 96.042 97.045 318 200.24 201.24
255 99.042 100.04 319 203.05 204.06
256 102.09 103.09 320 204.03 205.03
257 104.11 105.11 321 204.12 205.13
258 105.04 106.05 322 205.07 206.07
259 107.05 108.06 323 205.1 206.1
260 109.03 110.03 324 206.06 207.06
261 113.06 114.06 325 209.11 210.12
262 113.1 114.1 326 214.25 215.26
263 115.04 116.04 327 216.92 217.93
264 115.11 116.12 328 217.08 218.09
265 117.09 118.09 329 217.1 218.11
266 118.09 119.09 330 217.16 218.16
267 120.07 121.07 331 218.14 219.14
268 121.06 122.07 332 219.03 220.03
269 123.04 124.05 333 226.01 227.02
270 124.05 125.05 334 228.27 229.27
271 128.02 129.02 335 230.25 231.25
272 129.05 130.06 336 233.08 234.08
273 129.09 130.09 337 236.07 237.07
274 129.13 130.13 338 236.11 237.12
275 130.16 131.16 339 237.15 238.15
276 132.1 133.11 340 239.16 240.16
277 133.09 134.09 341 241.07 242.07
278 135.1 136.1 342 242.1 243.1
279 136.02 137.02 343 242.28 243.29
280 137.07 138.07 344 245.08 246.08
281 139.05 140.05 345 253.14 254.14
282 139.07 140.08 346 257.04 258.05
283 139.11 140.12 347 257.15 258.15
284 140.07 141.07 348 261.13 262.13
285 141.09 142.09 349 265.11 266.11
286 142.05 143.05 350 267.16 268.16
287 143.11 144.11 351 274.27 275.28
288 145.03 146.03 352 277.05 278.05
289 145.12 146.13 353 277.1 278.11
290 147.11 148.12 354 280.09 281.1
291 148 149.01 355 284.33 285.33
292 149.09 150.1 356 293.02 294.02
293 150.06 151.06 357 293.24 294.25
294 154.08 155.09 358 296.07 297.07
295 155.07 156.07 359 301.14 302.14
296 155.11 156.11 360 305.16 306.16
297 157.08 158.09 361 309.2 310.21
298 157.12 158.13 362 313.11 314.11
299 158.96 159.97 363 317.11 318.12
300 159.07 160.07 364 332.33 333.33
301 161.09 162.1 365 335.01 336.01
302 162.11 163.12 366 359.11 360.12
303 166.09 167.09 367 360.32 361.33
304 167.1 168.11 368 368.42 369.43
305 169.05 170.05 369 370.35 371.36
306 169.12 170.13 370 376.3 377.3
307 173.06 174.06 371 398.24 399.24
308 173.08 174.08 372 413.27 414.27
309 177.09 178.09 373 424.28 425.29
310 179.1 180.11 374 425.14 426.14
311 182.08 183.08 375 429.24 430.24
312 183.06 184.07 376 461.31 462.32
313 183.14 184.14 377 475.33 476.33
314 185.11 186.12 378 487.2 488.2
315 189.05 190.06 379 507.27 508.27
316 191.1 192.11 380 523.25 524.25
TABLE 2. Potential labeled ions in negative ion mode
No. M M+1 M+2 M+3 M+4 M+5 No. M M+1 M+2 M+3 M+4 M+5
1 114.056 119.0729 63 146.0652 149.0753 150.0787
2 128.0354 133.0521 64 147.0492 148.0527 149.056 150.0593 151.0628
3 129.0194 134.0364 65 148.0333 149.0367 150.04 151.0433 152.0467
4 129.0306 134.0469 66 156.9908 157.9942 161.0037
5 145.0143 150.031 67 173.0089 177.0225
6 145.0619 149.0753 150.0787 68 174.0408 178.0543
7 146.0459 147.0493 148.0527 149.056 150.0593 151.0628 69 189.989 194.0023
8 147.03 148.0333 149.0367 150.04 151.0433 152.0467 70 191.0198 193.0266 195.0328
9 149.0341 154.051 71 200.0176 204.031
10 168.0278 173.0448 72 205.0077 207.0145 209.0211
11 169.0118 172.0218 174.0288 73 211.9707 215.984
12 181.0379 186.0553 74 212.8869 216.9002
13 183.0356 188.0525 75 221.9996 226.0131
14 188.9862 194.0023 76 247.9474 251.9609
15 201.9968 206.0106 207.0145 77 263.9793 267.9931
16 203.0203 208.0372 78 329.0615 331.0683 333.075
17 204.0045 207.0145 209.0211 79 118.0227 119.026 121.0329
18 205.0175 210.0342 80 133.0336 135.0403 136.0437
19 205.992 207.9987 211.0086 81 134.0177 135.0211 136.0247 137.0277
20 206.0016 211.0183 82 157.9942 161.0037
21 206.9855 212.0024 83 192.0232 193.0266 195.0328
22 213.0493 215.0561 218.066 84 197.9631 200.9726
23 214.0333 217.0432 218.0466 219.0502 85 199.9214 202.931
24 215.0174 220.0339 86 204.9884 207.9987
25 225.9865 228.9965 231.0032 87 215.056 218.066
26 226.9706 231.9873 88 319.9215 322.9316
27 227.0652 232.0815 89 154.9187 156.9253
28 227.9835 233.0002 90 172.0222 174.0288
29 228.9675 233.9846 91 176.9359 178.943
30 229.033 234.0498 92 102.9569 103.9603
31 236.0152 241.032 93 104.9539 105.9573
32 236.9993 242.0162 94 113.9934 114.9968
33 250.0308 255.0476 95 116.9725 117.9758
34 260.9801 265.9959 96 118.9695 119.9729
35 261.963 266.9798 97 128.9596 129.9629
36 262.976 263.9793 267.9931 98 130.0873 131.0908
37 263.96 268.9768 99 141.0169 142.0203
38 266.0045 271.0214 100 152.996 153.9994
39 271.0079 276.0247 101 171.0066 172.0099
40 283.9449 288.9617 102 178.9727 179.9762
41 284.9286 289.946 103 184.9599 185.9633
42 285.942 290.9589 104 185.0222 186.0256
43 293.9739 298.9906 105 188.9816 189.985
44 306.0764 307.0798 308.0828 309.0866 310.0897 311.0933 106 194.9887 195.992
45 307.0799 309.0866 310.0897 311.0933 312.0968 107 198.9756 199.979
46 320.9345 325.9515 108 209.0043 210.0075
47 328.0583 329.0618 331.0683 333.075 109 215.0328 216.036
48 364.035 369.052 110 218.1033 219.1068
49 366.0315 371.0484 111 223.02 224.0234
50 386.0168 391.0337 112 227.9448 228.948
51 388.0138 393.0307 113 242.1762 243.1794
52 443.9754 448.9926 114 252.9473 253.9507
53 102.0561 106.0696 115 276.9916 277.9951
54 103.0401 107.0536 116 291.0074 292.0108
55 115.0037 119.0172 117 297.1528 298.1562
56 117.0194 118.0227 119.026 121.0329 118 311.1686 312.1719
57 123.9986 128.0121 119 325.1841 326.1874
58 129.0387 133.0521 120 339.1996 340.203
59 130.0228 134.0364 121 372.3035 373.307
60 132.0302 133.0336 135.0403 136.0437 122 382.3323 383.3357
61 133.0143 134.0177 135.0211 136.0247 137.0277 123 396.3478 397.3513
62 142.9752 143.9787 146.988
TABLE 3 labeled ions and their secondary mass spectral information in positive ion mode
Figure BDA0002810293240000111
TABLE 3. Marked ions and their secondary mass spectral information under positive ion mode
Figure BDA0002810293240000121
TABLE 3. Marked ions and their secondary mass spectral information under positive ion mode
Number of Name of Compound Number of marks Number of precise mass Second level information (relative intensity)
39 Unknown_p32 M+0 198.0372 198.0367(1)
39 Unknown_p32 M+4 202.0506 202.0505(1)
40 Unknown_p33 M+0 199.9904 62.9817(0.51),199.9904(1)
40 Unknown_p33 M+4 204.0039 62.9817(0.3),204.004(1)
41 Unknown_p34 M+0 223.1111 223.1117(1)
41 Unknown_p34 M+4 227.1252 227.1251(1)
42 Unknown_p35 M+0 236.9979 132.9871(1.81),132.9871(1.81),236.998(1)
42 Unknown_p35 M+4 241.0113 134.9938(0.82),135.9971(0.78),241.0111(1)
43 Unknown_p36 M+0 257.949 62.9817(0.61),155.0271(1.69),183.0222(2.1),199.9904(5.59),257.9487(1)
43 Unknown_p36 M+4 261.9623 62.9817(0.32),159.0406(1.42),187.0354(0.89),204.0039(3.94),261.9621(1)
44 Unknown_p37 M+0 377.0815 297.0884(0.3),377.0817(1)
44 Unknown_p37 M+2 379.088 299.0951(0.32),379.088(1)
45 Unknown_p38 M+0 88.0392 88.0391(1)
45 Unknown_p38 M+3 91.0493 91.0492(1)
46 Unknown_p39 M+0 214.0061 214.006(1)
46 Unknown_p39 M+3 217.0164 217.0159(1)
47 Unknown_p40 M+0 214.9901 62.9818(0.85),214.99(1)
47 Unknown_p40 M+3 218.0004 62.9818(0.91),218.0002(1)
48 Unknown_p41 M+0 215.016 215.0158(1)
48 Unknown_p41 M+2 217.0229 217.0222(1)
49 Unknown_p42 M+0 369.3512 369.3519(1)
49 Unknown_p42 M+2 371.3579 371.3576(1)
50 Succinate semialdehyde M+0 103.0388 70.9795(1)
50 Succinate semialdehyde M+4 107.0522 70.9795(1)
51 Ornithine M+0 133.097 74.0235(1)
51 Ornithine M+5 138.1139 76.0302(1)
52 Putrescine M+0 89.1072 72.0806(1)
52 Putrescine M+4 93.1207 76.094(1)
53 Asparagine M+0 133.0607 74.0235(1)
53 Asparagine M+4 137.074 76.0302(1)
54 Sperimidine M+0 146.1651 72.0806(1)
54 Sperimidine M+4 150.1785 76.094(1)
55 Alanine M+0 90.0549 73.0839(1)
55 Alanine M+3 93.0649 76.094(1)
TABLE 4. Labeled ions and their secondary mass spectral information in anion mode
Figure BDA0002810293240000141
TABLE 4. Marked ions and their second mass spectral information under negative ion mode
Figure BDA0002810293240000151
The analysis method can carry out quantitative analysis on the stable isotope labeled metabolites in a small amount of cells, and the analysis time is greatly shortened by direct sample injection. The method has the advantages of simple pretreatment, economy, high efficiency, high sensitivity and high flux.

Claims (1)

1. A stable isotope labeling metabolic flow analysis method based on chip nanoliter electrospray mass spectrometry is characterized by comprising the following steps:
(1) Directly extracting metabolites from cells by adopting methanol/water; the cells are cultured in two culture media respectively, one is a stable isotope labeling culture medium, and the other is an unstable isotope labeling culture medium; obtaining two cell metabolites which contain stable isotope labeling metabolites and contain metabolites which are not labeled by the stable isotope;
(2) Transferring the two cell metabolites into a sample injection disc respectively, adding a spray solvent, and directly injecting the mixture into a mass spectrometer through a chip-based multichannel nanoliter electrospray ion source;
(3) Acquiring primary mass spectrum information and secondary mass spectrum information by adopting a full-scanning and parallel reaction monitoring mode, and finding out a metabolite marked by a stable isotope through primary mass spectrum information matching and secondary mass spectrum information matching;
(4) Quantifying the metabolite marked by the stable isotope in the sample by adopting a parallel reaction monitoring mode;
the cells in the step (1) are respectively cultured in two culture media, one is a stable isotope labeling culture medium which contains stable isotope labeling metabolites 13 C 6 -a glucose, 13 c-1,2-glucose, 13 C 3 -pyruvic acid, 13 C 5 -a source of glutamine, 15 N 2 -a source of glutamine, 13 C 5 - 15 N 2 -a source of glutamine, 2 H 3 -one or more than two of serine; the other is an unstable isotope labeled culture medium, which contains metabolites that are not labeled with stable isotopes, and adopts unstable isotope labeling corresponding to stable isotope labeling and stable isotope labeling in concentration and stable isotope labeled culture mediumIsotopically labeled metabolites are consistent; culturing cells in 6-well, 12-well, 24-well, or 96-well or 10cm culture plates to make the cell density of each well reach 50% -90%; discarding the culture medium and washing twice with PBS; counting the cells, adding 50-100 mu L of 60-80% methanol/water (v/v) extracting agent into each 10000-20000 cells, wherein the extracting agent contains methionine sulfone and camphorsulfonic acid sodium salt with final concentration of 5-20 mu M respectively as internal standard; covering with aluminum foil paper and sealing film, standing at 3-5 deg.C for 30-40min to extract metabolite; transferring 20 to 40 mu L of the extracting solution into a sample plate in the step (2), and adding a spray solvent with the volume equal to that of the extracting solution into each hole, namely 20 to 40 mu L of the spray solvent; directly injecting the nano-liter electrospray ion source into a mass spectrometer through a chip-based multi-channel nano-liter electrospray ion source;
under the positive ion detection mode, the spraying solvent is 60-80% methanol/water (v/v) and contains 0.3-0.5% formic acid (v/v); under the negative ion detection mode, the spraying solvent is 60-80% methanol/water (v/v), ammonium acetate containing 10-30mM and 0.03-0.05% formic acid (v/v);
performing mass spectrometry on the cell extracting solution cultured in the stable isotope labeling culture medium and the cell extracting solution cultured in the non-stable isotope labeling culture medium by adopting a full scanning and parallel reaction monitoring mode in the step (3), and finding out the metabolite labeled by the stable isotope through matching of a primary mass spectrum and a secondary mass spectrum;
the specific process is as follows:
(1) First-order mass spectrum matching, finding potential labeled metabolites: analyzing a cell extracting solution cultured in a stable isotope labeling culture medium and a cell extracting solution cultured in an unstable isotope labeling culture medium by adopting a full scanning mode; filtering by primary mass spectrometry to obtain characteristic ions which are not marked and stably exist in a marked cell extracting solution, wherein the signal-to-noise ratio is less than 3, less than 60-80% of metabolites appear in repeated samples for more than 3 times, and the metabolites existing in blank samples are filtered; wherein the blank sample refers to a blank solvent without containing a cell sample, namely a mixed solution of an extracting agent and a spraying solvent;
calculating the accurate mass number of the corresponding isotope on the label as M + n according to the accurate mass number of the characteristic ions stably existing in the unlabeled sample as M, wherein n is the number of atoms marked by the stable isotope and is matched with the characteristic ions stably existing in the labeled cell extracting solution; the matching rules are equal under the mass deviation of 5-15 ppm; if there is a match, the metabolite is considered to be a potential labeled metabolite; if not, neglecting;
(2) Matching the secondary mass spectrum, and confirming the labeled metabolite information; aiming at potential labeled metabolites, a parallel reaction monitoring mode is adopted to obtain secondary mass spectrum information;
extracting secondary mass spectrograms with accurate mass numbers M and M + n from a stable isotope labeled sample respectively, generating all secondary ion primary and secondary ions → daughter ions according to M, abbreviated as M → Mp, calculating the accurate mass number of the stable isotope labeled secondary ions, and matching with the secondary mass spectrogram of M + n, wherein the secondary mass spectrogram of M + n is the primary ions → the daughter ions, abbreviated as M + n → Mp + M, M refers to the number of atoms labeled by the stable isotope, and M is less than or equal to n; the matching rules are equal under the mass deviation of 5-20 ppm; if not, neglecting; if the values are matched, calculating the ratio of the Mp + m intensity to the Mp intensity; meanwhile, extracting M → Mp and M + n → Mp + M from a sample without stable isotope labeling, calculating the ratio of the strength of Mp + M to the strength of Mp, and if the value obtained by multiplying the ratio by 1.0 to 1.2 is smaller than the ratio of the strength of Mp + M to the strength of Mp in the sample with stable isotope labeling, considering that M and M + n are a pair of non-labeled and labeled metabolites and respectively contain secondary fragments Mp and Mp + M;
according to the above rules, metabolites labeled by stable isotopes can be found, and the primary and secondary mass spectrum information thereof can be used for qualitative and quantitative analysis;
quantifying the metabolite marked by the stable isotope by adopting a parallel reaction monitoring mode in the step (4);
the conditions for the parallel reaction monitoring mode were: the maximum ion collection time is 100 to 200ms, each 0.1 to 0.3s is a time period, and no more than 50 ions are contained in one time period so as to ensure that each ion is collected at least to more than 5 points;
meanwhile, the internal standard intensity is collected in the whole section; for each ion, the intensity was divided by the internal standard intensity at the same time, and the average of 5 or more points was taken as a semi-quantitative result.
CN202011387929.6A 2020-12-01 2020-12-01 Analysis method of stable isotope labeling metabolic flow based on chip nanoliter electrospray mass spectrum Active CN114577916B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011387929.6A CN114577916B (en) 2020-12-01 2020-12-01 Analysis method of stable isotope labeling metabolic flow based on chip nanoliter electrospray mass spectrum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011387929.6A CN114577916B (en) 2020-12-01 2020-12-01 Analysis method of stable isotope labeling metabolic flow based on chip nanoliter electrospray mass spectrum

Publications (2)

Publication Number Publication Date
CN114577916A CN114577916A (en) 2022-06-03
CN114577916B true CN114577916B (en) 2022-12-09

Family

ID=81766913

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011387929.6A Active CN114577916B (en) 2020-12-01 2020-12-01 Analysis method of stable isotope labeling metabolic flow based on chip nanoliter electrospray mass spectrum

Country Status (1)

Country Link
CN (1) CN114577916B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006337176A (en) * 2005-06-02 2006-12-14 Eisai R & D Management Co Ltd Determination method of metabolite
WO2018174891A1 (en) * 2017-03-23 2018-09-27 Mprobe Inc. Quantitative targeted metabolomic analysis based on the mixture of isotope-and nonisotope-labeled internal standards
JP2019024326A (en) * 2017-07-25 2019-02-21 大陽日酸株式会社 Method of producing labelled metabolite, method of quantifying metabolite, and labelled metabolite production kit

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6764817B1 (en) * 1999-04-20 2004-07-20 Target Discovery, Inc. Methods for conducting metabolic analyses
US8510054B2 (en) * 2004-02-05 2013-08-13 Ajinomoto Co., Inc. Intracellular metabolic flux analysis method using substrate labeled with isotope

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006337176A (en) * 2005-06-02 2006-12-14 Eisai R & D Management Co Ltd Determination method of metabolite
WO2018174891A1 (en) * 2017-03-23 2018-09-27 Mprobe Inc. Quantitative targeted metabolomic analysis based on the mixture of isotope-and nonisotope-labeled internal standards
JP2019024326A (en) * 2017-07-25 2019-02-21 大陽日酸株式会社 Method of producing labelled metabolite, method of quantifying metabolite, and labelled metabolite production kit

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
A complete workflow for high-resolution spectral-stitching nanoelectrospray direct-infusion mass-spectrometry-based metabolomics and lipidomics;Andrew D Southam 等;《Protocol》;20170112;第12卷(第2期);第255-273页 *
An optimized protocol for metabolome analysis in yeast using direct infusion electrospray mass spectrometry;Juan I Castrillo 等;《Phytochemistry》;20030331;第62卷;第929-937页 *
代谢组学分析技术及代谢物鉴定;王超 等;《国际药学研究杂志》;20101031;第37卷(第5期);第355-360页 *

Also Published As

Publication number Publication date
CN114577916A (en) 2022-06-03

Similar Documents

Publication Publication Date Title
Freund et al. Recent advances in stable isotope-enabled mass spectrometry-based plant metabolomics
Marshall et al. Beyond the paradigm: Combining mass spectrometry and nuclear magnetic resonance for metabolomics
CN111505141B (en) High-throughput screening method for non-target biomarkers based on pollutant metabolic disturbance
CN111579665B (en) UPLC/HRMS-based metabonomics relative quantitative analysis method
AU2993401A (en) Method of non-targeted complex sample analysis
Kirkwood et al. Simultaneous, untargeted metabolic profiling of polar and nonpolar metabolites by LC‐Q‐TOF mass spectrometry
Burg et al. Proteomics of extremophiles
CN108693294A (en) A variety of amino metabolins based on N- ethylization methods synchronize quantitative analysis method
CN109060983A (en) A kind of method of liquid chromatography-tandem mass spectrometry detection metanephrine substance
CN111638293A (en) LC-MS/MS detection method for simultaneously determining amino acids and nucleotides in animal tissues
Yang et al. Gas chromatography–mass spectrometry with chemometric analysis for determining 12C and 13C labeled contributions in metabolomics and 13C flux analysis
CN115015422A (en) Liquid chromatography tandem mass spectrometry detection method for 3-chloro-1, 2-propanediol in soy sauce
CA2547755C (en) Method for analysing metabolites
CN102980968A (en) Liquid chromatogram tandem mass spectrum measuring method for creatinine in urine
CN114577916B (en) Analysis method of stable isotope labeling metabolic flow based on chip nanoliter electrospray mass spectrum
Zhao et al. HDPairFinder: A data processing platform for hydrogen/deuterium isotopic labeling-based nontargeted analysis of trace-level amino-containing chemicals in environmental water
CN113138234A (en) Quantitative analysis method and kit for detecting various intestinal microorganism metabolites
Swann et al. Determination of amino acids and amines in mammalian decomposition fluid by direct injection liquid chromatography-electrospray ionisation-tandem mass spectrometry
Jaiswal et al. SWATH: A Data-Independent Tandem Mass Spectrometry Method to Quantify 13 C Enrichment in Cellular Metabolites and Fragments
CN113655223A (en) Multiplex amino acid quantitative method and kit development
US20210215668A1 (en) Method for Detecting Urinary Tract Infections and Sample Analysis Using Liquid Chromatography
WO2023002548A1 (en) Isotope distribution data production method
CN113960188B (en) Determination of 4, 4-di (dimethylamino) -4-methylamino-tritanol in sample by high performance liquid chromatography-tandem mass spectrometry
CN116818957B (en) Method for detecting content of sodium pentachlorophenolic acid and metabolite thereof in live pig sample
Bierla et al. Isotopologue pattern based data mining for selenium species from HILIC–ESI–Orbitrap–MS-derived spectra

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant